N-(2-((3-(3-(N-Allylsulfamoyl)-4-methoxyphenyl)-6-chloro-2-methylimidazo[1,2-b]pyridazin-8-yl)amino)ethyl)acetamide

ID: ALA3893537

PubChem CID: 134136768

Max Phase: Preclinical

Molecular Formula: C21H25ClN6O4S

Molecular Weight: 492.99

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CCNS(=O)(=O)c1cc(-c2c(C)nc3c(NCCNC(C)=O)cc(Cl)nn23)ccc1OC

Standard InChI:  InChI=1S/C21H25ClN6O4S/c1-5-8-25-33(30,31)18-11-15(6-7-17(18)32-4)20-13(2)26-21-16(12-19(22)27-28(20)21)24-10-9-23-14(3)29/h5-7,11-12,24-25H,1,8-10H2,2-4H3,(H,23,29)

Standard InChI Key:  GRHQJOYUBHIACN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 35  0  0  0  0  0  0  0  0999 V2000
    8.4705  -15.3390    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2600  -16.1315    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.0515  -15.9175    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2516  -14.4249    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.9524  -14.0132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9483  -13.1961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6532  -12.7845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6490  -11.9673    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9400  -11.5618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2350  -11.9734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5218  -11.5719    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5177  -10.7548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8045  -10.3492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2226  -10.3390    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6656  -14.4188    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3705  -14.0072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3623  -13.1859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1410  -12.9275    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6237  -13.5900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4409  -13.5818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1461  -14.2540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4045  -15.0286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8629  -15.6406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1212  -16.4153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9213  -16.5779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1797  -17.3526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6380  -17.9646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4630  -15.9660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5672  -16.8921    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2087  -15.1913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6829  -17.7636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3781  -16.9991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4916  -17.8810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
  5 15  2  0
 15 16  1  0
 16 17  1  0
  7 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 16 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 25 28  1  0
 28  2  1  0
  2 29  1  0
 28 30  2  0
 22 30  1  0
 29 32  1  0
 31 32  1  0
 31 33  2  0
M  END

Alternative Forms

  1. Parent:

    ALA3893537

    ---

Associated Targets(Human)

PI4K2A Tbio PI4-kinase type II (62 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PI4KA Tchem PI4-kinase alpha subunit (184 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PI4KB Tchem PI4-kinase beta subunit (1593 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 492.99Molecular Weight (Monoisotopic): 492.1347AlogP: 2.38#Rotatable Bonds: 10
Polar Surface Area: 126.72Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 9.47CX Basic pKa: 3.20CX LogP: 1.07CX LogD: 1.07
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.29Np Likeness Score: -1.55

References

1. Mejdrová I, Chalupská D, Plačková P, Müller C, Šála M, Klíma M, Baumlová A, Hřebabecký H, Procházková E, Dejmek M, Strunin D, Weber J, Lee G, Matoušová M, Mertlíková-Kaiserová H, Ziebuhr J, Birkus G, Boura E, Nencka R..  (2017)  Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIβ (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical Biology.,  60  (1): [PMID:28004945] [10.1021/acs.jmedchem.6b01465]

Source